Table 3.
Multivariate analysis for predictors of myopenia in CRC patients
Variable | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
Gender (female) | 2.33 | 1.27–4.3 | 0.007 * | 2.5 | 1.13–5.53 | 0.024 * |
Age (>68 years old)a | 1.57 | 0.86–2.85 | 0.14 | |||
Histological type (undifferentiated) | 0.46 | 0.16–1.29 | 0.14 | |||
Location (left) | 0.62 | 0.33–1.17 | 0.14 | |||
T classification (pT3/4) | 2.06 | 1.04–4.05 | 0.036 * | 1.07 | 0.41–2.79 | 0.89 |
Vessel involvement (present) | 1.93 | 1.05–3.53 | 0.034 * | 0.75 | 0.3–1.88 | 0.54 |
Lymphatic vessel involvement (present) | 2.58 | 1.21–5.5 | 0.014 * | 1.97 | 0.62–6.26 | 0.25 |
Lymph node metastasis (present) | 2.72 | 1.47–5.04 | 0.001 * | 1.71 | 0.72–4.07 | 0.22 |
Distant metastasis (present) | 3.06 | 1.49–6.31 | 0.002 * | 1.42 | 0.5–4.07 | 0.51 |
Pre‐operative haemoglobin (low)b | 4.11 | 2.18–7.77 | <0.0001 * | 3.1 | 1.36–7.08 | 0.007 * |
Pre‐operative lymphocytes (low)b | 0.55 | 0.27–1.09 | 0.09 | |||
Pre‐operative albumin (low)b | 4.69 | 2.44–9.02 | <0.0001 * | 3.21 | 1.36–7.58 | 0.008 * |
Pre‐operative serum miR‐203 (high)b | 5.46 | 2.32–12.8 | 0.0001 * | 5.16 | 1.8–14.8 | 0.002 * |
CI, confidence interval; CRC, colorectal cancer; OR, odds ratio.
The median age at surgery is 68 years in CRC patients.
Cut‐off thresholds of each covariate were determined by receiver operating characteristic analysis with Youden's index for myopenia in each gender of CRC patients.
P < 0.05. Bold font means significant p‐value in these tables.